Therapeutic Effects of Autologous Adipose Tissue-Derived Stromal Vascular Fraction (ADSVF) Implantation for Non-traumatic Osteonecrosis of the Femoral Head: A Double-Blind Randomized Clinical Study with or without ADSVF.

Hyundae Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•Subjects with non-traumatic femoral head avascular necrosis who consent to this study
•- Subjects who have not received other treatments such as core decompression and multiple trepanation for avascular necrosis of the femoral head in the relevant area
•- Before the femoral head collapses or when the depth of collapse is less than 2 mm
•- Subjects with more than 30% necrosis of the femoral head

•- Subjects with a depth of femoral head collapse of 2 mm or more
•- Subjects with more than 30% necrosis of the femoral head
•- Subjects who have received treatment of core decompression and multiple trepanation for avascular necrosis of the femoral head in the relevant area
•- Subjects taking osteoporosis treatments such as bisphosphonates or parathyroid hormones
•- Subjects who are taking immunosuppressants or cytotoxic agents or who need to take them during the test period
•- Subjects who must continuously take corticosteroids for treatment purposes
•- Subjects who are unable to undergo MRI (magnetic resonance imaging) due to artificial pacemakers, metallic hip joints, prosthetics, etc.
•- Subjects who are pregnant or breastfeeding
•- Subjects currently suffering from infectious diseases including HIV and hepatitis
•- Subjects with serious diseases that may affect this clinical trial: cardiovascular disease, tumor, kidney disease, endocrine disease such as decreased bone metabolism, increased bone metabolism and thyroid disease, autoimmune disease, etc.
•- Subjects who participated in another clinical trial within 3 months of participating in this clinical trial
•- In other cases where the researcher determines that participation in this study is inappropriate

发起方

Hyundae Hospital